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Abstract To investigate the roles of various hematopoietic cell-
specific adapter proteins in T cell receptor (TCR)-signaling
leading to nuclear factor of activated T cell (NF-AT) and nuclear
factor of UB (NF-UB) activation, we reconstituted TCR-signaling
with CD8/j, various protein tyrosine kinases (PTKs), and
adapter proteins in a non-lymphoid cell line, 293T. We show
that SLP-76 and BLNK, but not LAT, effectively co-operated
with Syk and Tec family PTKs to activate NF-AT and NF-UB.
We also show that Tec family PTKs enhanced endogenous
phospholipase C (PLC)-Q1 phosphorylation induced by CD8/j
and Syk in 293T cells. These results imply that PLC-Q1 may play
a critical role in a hematopoietic cell-specific adapter protein-
mediated NF-AT and NF-UB activation in a non-lymphoid
cell. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Multiple protein tyrosine kinases (PTKs) are required to
convey signals from T cell antigen receptors (TCRs) and B
cell antigen receptors (BCRs). Previous biochemical studies
have shown that TCR- and BCR-signaling events involve
the activation of two families of PTKs; Src PTKs (Lck, Fyn
and Lyn), and Syk/Zap-70 PTKs. The Src PTKs phosphory-
late the two conserved tyrosine residues in the immunorecep-
tor tyrosine-based activation motif (ITAM), and the phos-
phorylated ITAMs mediate the interaction of Syk/Zap-70
PTKs with the receptor, amplifying the TCR- and BCR-trig-
gered signals by phosphorylating additional intracellular sub-
strates including phospholipase C-Q (PLC-Q), Cbl and Vav
[1,2]. Tyrosine phosphorylation of PLC-Q induces its enzy-
matic activity, leading to the activation of the inositol phos-
pholipid pathway, followed by activation of protein kinase C
(PKC) and the increase in intracellular calcium, resulting in
the activation of the IL-2 promoter which is driven by di¡er-
ent transcription factors, such as nuclear factor of activated
T cells (NF-AT) and nuclear factor of UB (NF-UB) [3,4].
TCR- and BCR-signaling require activation of Syk/Zap-70
and Src family PTKs, but requirements for other tyrosine ki-
nases were less clear. Recently, it was found that mutations in
the gene encoding a Tec family PTK, Bruton’s tyrosine kinase
(Btk), cause the B cell de¢ciency disease in humans and mice;
X-linked agammaglobulinemia in humans and X-linked im-
munode¢ciency in mice [5,6]. In vivo and in vitro studies in-
dicate that Btk is essential for B cell survival and proliferation
in response to BCR stimulation. Recently, combined deletion
in mice of other two Tec PTKs, Rlk and Itk, has been shown
to cause marked defects in TCR responses including cell pro-
liferation and IL-2 production [7]. In these mice, molecular
events immediately downstream from the TCR were intact,
while intermediate molecular events including inositol tris-
phosphate production, calcium mobilization, and mitogen-
activated protein kinase activation were impaired, suggesting
Tec PTKs as critical regulators of TCR-signaling required for
PLC-Q1 activation.
Most reconstitution studies with immune receptors and
PTKs in non-lymphoid cells failed to activate these pathways,
suggesting the requirement for additional lymphoid-speci¢c
adapter proteins [8,9]. Recently, an array of immune cell-spe-
ci¢c adapter proteins have been identi¢ed. These adapters in-
clude linker for activation of T cell (LAT), SH2 domain-con-
taining leukocyte protein of 76 kDa (SLP-76), SLP-76-
associated protein of 130 kDa (SLAP-130) and B cell linker
protein (BLNK), which lack enzymatic and transcriptional
domains, but they have multiple motifs and domains that
allow binding to other proteins. It is believed that they inte-
grate signals from surface receptors with their multiple bind-
ing sites and the potential to create various combinations of
multiprotein complexes [9,10].
In the previous study, we developed a novel system to ex-
plore the TCR- and BCR-signaling pathway using a non-lym-
phoid cell line, 293T, which is commonly used for e⁄cient
expression of various vectors [11]. In this system, Syk, but
not Zap-70, stimulated the NF-AT-mediated transcriptional
response in the presence of CD8/j chimeric molecules. We
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also showed that this NF-AT activation was mediated by
endogenous PLC-Q1 and completely inhibited by inhibitors
for calcineurin pathway, CsA and FK506. In this report, we
demonstrate that additional expressions of lymphoid-speci¢c
adapter molecule, SLP-76 and BLNK, but not LAT, en-
hanced both NF-AT and NF-UB activation. They also en-
hanced endogenous PLC-Q1 phosphorylation induced by
CD8/j and Syk. Finally, we show that an additional expres-
sion of Tec family PTKs also remarkably enhanced NF-AT
and NF-UB activation as well as enhancement of endogenous
PLC-Q1 phosphorylation induced by CD8/j and Syk. These
results imply that this novel system in non-lymphoid cells may
provide a useful tool to delineate or identify the regulatory
molecules for the TCR- and BCR-mediated NF-AT and NF-
UB activation.
2. Materials and methods
2.1. Cell lines and reagents
A rat basophilic leukemia cell line, RBL-2H3, was kindly donated
by Dr. T. Takai (Tohoku University, Japan). A stable transformant
(RBL-CD8/j) expressing CD8/j was established by transfecting
pTfneo-CD8/j and maintained in DMEM medium supplemented
with 10% fetal calf serum in the presence of 100 Wg/ml of G418. A
human embryonic kidney cell line, 293T, was maintained in DMEM
medium supplemented with 10% fetal calf serum. Expression vectors,
CD8/j, NFAT1-C, NF-AT-LUC, Zap-70, Lck, Tec, FLAG-tagged
LAT, and Myc-tagged Cbl were previously described [11,12]. Expres-
sion vectors, NF-UB-LUC (p55IgU-LUC) [13], TecKM [14], FLAG-
tagged SLP-76, FLAG-tagged SLAP-130, Myc-tagged BLNK, Myc-
tagged Cbl, FLAG-tagged LAT and Vav1 were kindly provided by
Dr. T. Fujita, Dr. N. Watanabe (Tokyo Metropolitan Inst. Med. Sci.,
Tokyo, Japan), Dr. S. Tsukada (Osaka University, Osaka, Japan), Dr.
G.A. Koretzky (University of Iowa, Iowa City, IA, USA), Dr. T.
Kurosaki (Kansai Medical University, Moriguchi, Japan), Dr. A. Ull-
rich (Max-Planck-Inst. fur Biochem., Martinsried, Germany) and Dr.
H. Mano (Jichi Med. Sch., Tochigi, Japan), respectively. U73122 was
purchased from Calbiochem (La Jolla, CA, USA).
2.2. Antibodies and £ow cytometry analysis
Monoclonal anti-OKT8 was purchased from CALTAG Laborato-
ries (Burlingame, CA, USA). Anti-Myc monoclonal antibody (mAb)
9E10, anti-CD3j, anti-Syk, anti-PLC-Q1, anti-PLC-Q2, anti-Vav1,
anti-Cbl and anti-SLP-76 were purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA, USA). Anti-FLAG M2 and anti-phospho-
tyrosine mAb 4G10 were purchased from Upstate Biotechnology
(Lake Placid, NY, USA). Cell staining and £ow cytometry analysis
were performed according to the manufacturer’s instructions. Cells
were stained with PE-anti-CD8 antibody (Beckton Dickinson, Moun-
tain View, CA, USA). The stained cells were analyzed using FACS-
Calibur (Beckton Dickinson, Mountain View, CA, USA).
2.3. Transfections and luciferase assay
10 Wg of pTfneo-CD8/j vector was transfected into 1U107 of RBL-
2H3 cells by electroporation with single pulse conditions of 250 V and
975 WF (Gene Pulser II, Bio-Rad). The selection and cloning for neo-
mycin-resistant cells were performed in the presence of 100 Wg/ml
geneticin (Life Technologies, Inc.). 293T cells were plated in 6-cm
dishes or in 10-cm dishes and transfected by standard calcium precip-
itation protocol. The cells were harvested 48 h after transfection and
lysed in 100 Wl of PicaGene Reporter Lysis Bu¡er (Toyo Ink, Tokyo,
Japan) and assayed for luciferase and L-galactosidase activities ac-
Fig. 1. Speci¢c tyrosine phosphorylation of adapter proteins by PTKs in 293T cells. 293T cells were transfected with CD8/j (5 Wg) together
with each PTK; Syk (5 Wg), Lck (5 Wg), Tec (5 Wg), Zap-70 (5 Wg) or Btk (5 Wg) (A), or together with each PTK (5 Wg) and 5 Wg of Vav1,
Cbl, PLC-Q2, SLP-76, BLNK, LAT, or SLAP-130 (B). After 48 h transfection, cells were lysed and immunoprecipitated with each antibody or
anti-Tag antibody. The immunoprecipitate was probed with an anti-phosphotyrosine antibody as indicated (anti-PY, upper panels). The blot
was stripped and reprobed with respective antibody (lower panels).
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cording to the manufacturer’s instructions. Luciferase activities were
normalized to the L-galactosidase activities. Three or more independ-
ent experiments were carried out.
2.4. Immunoprecipitation and immunoblotting
The transfected 293T cells were lysed in lysis bu¡er (50 mM Tris^
HCl, pH 7.4, 0.15 M NaCl, containing 1% NP-40, 1 mM sodium
orthovanadate, 1 mM phenylmethylsulfonyl £uoride and 10 Wg/ml
each of aprotinin, pepstatin and leupeptin).
The immunoprecipitates from cell lysates were resolved on 5^20%
SDS^PAGE and transferred to Immobilon (Millipore, Bedford, MA,
USA). The Immobilon ¢lters were then immunoblotted with each
antibody. Immunoreactive proteins were visualized using an enhanced
chemiluminescence detection system (Amersham Pharmacia Biotech,
Tokyo, Japan).
3. Results and discussion
3.1. Speci¢c tyrosine phosphorylation of adapter proteins by
PTKs in 293T cells
In the previous report, we demonstrated that ectopic ex-
pression of CD8/j and Syk activated NF-AT-dependent re-
porter gene transcription in 293T cells. To further reconstitute
the CD8/j- and Syk-mediated NF-AT activation in 239T cells,
we ¢rst examined tyrosine phosphorylation of adapter pro-
teins by Syk, Lck, Tec, Zap-70 and Btk in the presence of
CD8/j. As shown in Fig. 1A, endogenous PLC-Q1 was tyro-
sine-phosphorylated by Syk, but not Lck, Tec or Zap-70, as
previously reported [11]. Faint tyrosine phosphorylation of
endogenous PLC-Q1 was observed by expression of Btk. Nei-
ther endogenous Cbl nor Vav1 was tyrosine-phosphorylated
by each PTK examined.
Next, we examined tyrosine phosphorylation of ectopically
expressed adapter proteins by each PTK in 293T cells. As
shown in Fig. 1B, the equal tyrosine phosphorylation of
CD8/j by each PTK was observed. Ectopically expressed
Cbl was tyrosine-phosphorylated by Syk, Lck, and Btk, but
not Tec or Zap-70. Vav1 was phosphorylated by Syk and Lck,
but not Zap-70, whereas much less phosphorylation was in-
duced by Tec and Btk. Tyrosine phosphorylation of SLP-76
and BLNK was induced by Syk, Zap-70 and Btk, but not Lck
or Tec. Tyrosine phosphorylation of LAT was induced by Syk
and Lck, but not Tec, Zap-70 or Btk, whereas combination of
Lck and Zap-70 induced much more e¡ective tyrosine phos-
phorylation than Lck alone as previously described [15]. Each
PTK equally induced tyrosine phosphorylation of SLAP-130
as well as CD8/j. These results suggest that Syk can tyrosine-
phosphorylate all of the adapter molecules examined and is
useful for reconstitution of TCR- and BCR-signaling in 293T
cells.
3.2. Reconstitution of NF-AT- and NF-UB-signaling pathway in
293T cells
To investigate whether the phosphorylation of CD8/j and
adapter proteins induces NF-AT and NF-UB activation in
293T cells, we then transfected either NF-ATc and NF-AT-
LUC or NF-UB-LUC together with CD8/j and each individ-
ual PTK and each adapter protein expression construct into
Fig. 2. Reconstitution of NF-AT- and NF-UB-signaling pathway in 293T cells. (A^C) NF-AT reporter assay. 293T cells were transfected with
CD8/j (1 Wg), NF-ATc (1 Wg), NF-AT-LUC (1 Wg), L-gal (0.5 Wg) with or without Syk (0.5 Wg) and increasing amounts of Vav1, Cbl or PLC-
Q2 (A), or SLP-76, BLNK, or LAT (B), or Tec (0.5 Wg), TecKM (0.5 Wg), and an increasing amount of SLP-76 (C). (D^F) NF-UB reporter as-
say. 293T cells were transfected with CD8/j (1 Wg), NF-UB-LUC (1 Wg), L-gal (0.5 Wg) with or without Syk (0.5 Wg) and increasing amounts of
Vav1, Cbl or PLC-Q2 (D), or SLP-76, BLNK, or LAT (E), or Tec (0.5 Wg), TecKM (0.5 Wg), and an increasing amount of SLP-76 (F). 48 h
after transfection, cells were harvested and luciferase activity was determined. The result shown here is representative of at least three independ-
ent experiments with similar results. S.D. was less than 10%.
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293T cells, and the LUC activity was assayed. As described in
the previous report [11], the expression of Syk and CD8/j
induced a marked activation of NF-AT, whereas expression
of other PTKs (Lck, Tec and Zap-70) and CD8/j showed no
or very little e¡ect on the NF-AT activation. Simultaneous
expression of CD8/j and Syk was a prerequisite for the NF-
AT activation in 293T cells. In this study, we examined e¡ects
of the additional expression of adapter proteins on not only
NF-AT but also NF-UB activation in 293T cells. As shown in
Fig. 2A,E, neither ectopically expressed Cbl nor PLC-Q2 aug-
mented NF-AT and NF-UB activation. Signi¢cant Syk- and
CD8/j-dependent NF-UB activation was not observed in 293T
cells (Fig. 2E,F). However, ectopical expression of Vav1 alone
resulted in the NF-UB activation in 293T cells in the absence
of Syk (Fig. 2E), suggesting that Vav1 is a direct activator of
NF-UB pathway in 293T cells.
Next, we examined the e¡ect of lymphoid-speci¢c adapter
proteins, SLP-76, BLNK LAT on NF-AT and NF-UB activ-
ities. As shown in Fig. 2B, an additional expression of SLP-76
or BLNK resulted in the increase of Syk- and CD8/j-medi-
ated NF-AT in 293T cells coincident with their functions in
lymphoid cells. Additional expression of LAT showed a de-
crease of NF-AT activation (Fig. 2B), although LAT is shown
to be required for TCR-mediated activation of PLC-Q1 and
the Ras pathway in T cells [16]. This ¢nding may suggest that
LAT requires additional lymphoid-speci¢c adapter molecules
for its function or other negative regulator molecules may be
recruited by the phosphorylation of LAT by Syk in 293T cells.
We previously demonstrated that an additional expression
of Tec markedly augmented CD8/j and Syk-mediated NF-AT
activation [11], supporting the previous reports showing that
Btk/Tec and Syk family PTKs exert distinct e¡ects on calci-
um-signaling [17,18]. Furthermore, it was shown that Btk is
essential for activation of NF-UB via the BCR [5,6]. Thus, we
examined the e¡ect of Tec family PTKs, Tec and Btk with or
without SLP-76 on NF-AT and NF-UB activation in 293T. As
shown in Fig. 2C,F, Tec, but not TecKM (a kinase negative
mutant Tec), enhanced CD8/j- and Syk-mediated NF-AT ac-
tivation in 293T cells. Additional expression of SLP-76
showed a slight increase of CD8/j-, Syk- and Tec-mediated
Fig. 3. Enhanced activation of endogenous PLC-Q1 by Syk, CD8/j, Tec and adapter molecules and inhibition of NF-AT activation by a PLC
inhibitor, U73122. (A^C) 293T cells were transfected with CD8/j alone or CD8/j (5 Wg) and Syk (5 Wg) with or without SLP-76 (5 Wg), BLNK
(5 Wg) or LAT (5 Wg) (A), or with or without SLP-76 (5 Wg), BLNK (5 Wg), Tec (5 Wg), Btk (5 Wg) (B), or with or without SLP-76 (5 Wg), Tec
(5 Wg), or TecKM (5 Wg) (C). After 48 h, cells were lysed and immunoprecipitated with anti-PLC-Q1, anti-Cbl, anti-Vav1, anti-Tec, or anti-
CD3j, respectively. The immunoprecipitate with each antibody was probed with an anti-phosphotyrosine antibody as indicated (anti-PY, upper
panels). The blot was stripped and reprobed with respective antibody (lower panels). (D) E¡ect of U73122 on CD8/j/Syk/Tec/SLP-76-induced
NF-AT and NF-UB activation in 293T cells. 293T cells were transfected with CD8/j (1 Wg), Syk (0.5 Wg), L-gal (0.5 Wg) together with NF-ATc
(1 Wg), NF-AT-LUC (1 Wg) (left) or NF-UB-LUC (1 Wg) (right) and treated with increasing amounts of U73122 or DMSO. 48 h after transfec-
tion, cells were harvested and luciferase activity was determined. The result shown here is representative of at least three independent experi-
ments with similar results. S.D. was less than 10%.
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NF-AT activation. Interestingly, Tec expression induced the
marked increase of CD8/j- and Syk-mediated NF-UB activa-
tion, and additional expression of SLP-76 enhanced CD8/j-
Syk-Tec-mediated NF-UB activation in 293T cells. Btk also
showed a similar e¡ect on NF-AT and NF-UB activation in
293T cells (data not shown). These Tec PTKs or Vav1-medi-
ated NF-UB activation in 293T were completely inhibited by
co-expression of a dominant negative IUB (data not shown).
These results show that Tec PTKs, Vav1, and SLP-76 are
involved in CD8/j- and Syk-mediated NF-UB activation in
293T cells.
3.3. Enhanced tyrosine phosphorylation of the endogenous
PLC-Q1 by expression of adapter proteins in 293T
In the previous report [11] as well as in Fig. 1, we demon-
strated that the tyrosine phosphorylation of the endogenous
PLC-Q1, but not Cbl and Vav1, was induced by CD8/j and
Syk in 293T cells, the results indicating that endogenous PLC-
Q1 may play a pivotal role on the NF-AT activation induced
by CD8/j and Syk in 293T cells. We then examined the e¡ect
of the additional expression of adapter proteins on tyrosine
phosphorylation of endogenous PLC-Q1, Cbl and Vav1. As
shown in Fig. 3A, additional expression of adapter proteins,
SLP-76 and BLNK induced an increase of tyrosine phosphor-
ylation of endogenous PLC-Q1 when compared with that ob-
served with Syk and CD8/j. Moreover, tyrosine phosphory-
lation of endogenous Cbl, but not Vav1, was induced in the
presence of SLP-76, suggesting that phosphorylated SLP-76
can recruit additional adapter molecules in 293T cells. Con-
versely, expression of LAT resulted in a marked decrease of
tyrosine phosphorylation of PLC-Q1 by CD8/j and Syk. This
¢nding is in accordance with the data that SLP-76 and
BLNK, but not LAT, enhance CD8/j- and Syk-mediated
NF-AT activation in 293T cells (Fig. 2B). Furthermore, tyro-
Fig. 4. The signal through CD8/j induces tyrosine phosphorylation of Syk, Btk and Tec and adapter molecules in a CD8/j-expressing cell line,
RBL-2H3. Expression of surface CD8/j on RBL-CD8/j cells. RBL-2H3 (dotted line) or RBL-CD8/j (solid line) cells were stained with PE-
anti-CD8 and analyzed by £ow cytometry. (B) NF-AT and NF-UB activation by OKT8 in RBL-CD8/j cells. 1U107 of RBL-2H3 cells were
transfected with either NF-AT-LUC (15 Wg) or NF-UB-LUC (15 Wg) together with L-gal (10 Wg) by electroporation as described in Section 2.
24 h after transfection, cells were stimulated with control IgG, OKT8 antibody (5 Wg/ml) or ionomycin (1 WM) for an additional 6 h. Cells
were harvested and relative luciferase activities were measured. The result shown here is representative of at least three independent experiments
with similar results. S.D. was less than 10%. (C) RBL-CD8/j cells were stimulated for 15 min with OKT8 (5 Wg/ml). Cells were lysed and im-
munoprecipitated with each antibody. The immunoprecipitate was probed with an anti-phosphotyrosine antibody as indicated (anti-PY, upper
panel). The blot was stripped and reprobed with respective antibody (lower panel).
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sine phosphorylation of endogenous PLC-Q1 by CD8/j and
Syk was enhanced by additional expression of Tec or Btk in
presence of SLP-76 or BLNK (Fig. 3B), suggesting that these
adapter molecules recruit Tec PTKs to PLC-Q1 in 293T cells.
This enhancement of tyrosine phosphorylation of endogenous
PLC-Q1 by Tec was not observed by the expression of TecKM
(a kinase negative mutant Tec) (Fig. 3C). Recent study dem-
onstrated that the SH2-SH2-SH3 region of PLC-Q1 mediated
NF-UB activation in a rat ¢broblast cell line, 3Y1 [19]. It was
also demonstrated that TNF activates PLC-Q2 via an up-
stream PTK to induce activation of PKC and PTKs, leading
to NF-UB activation in NCI-H292 epithelial cells [20]. To
examine whether activation of endogenous PLC-Q1 is critical
in NF-AT and NF-UB activation in 293T cells or not, we
treated the transfected cells with U73122, an inhibitor of
PLC (Fig. 3D). Interestingly, U73122 had a signi¢cant inhib-
itory e¡ect on NF-AT activation. On the other hand, U73122
had no e¡ect on NF-UB activation in 293T cells, indicating
that PLC-Q1 enzyme activity itself is not crucial in NF-UB
activation as described previously [19]. The data show that
activation of endogenous PLC-Q1 is crucial in CD8/j- and
Syk-mediated NF-AT activation, but not NF-UB activation
in 293T cells.
3.4. The signal through CD8/j induces tyrosine phosphorylation
of Syk, Btk and Tec and adapter molecules in a stable
CD8/j-expressing cell line, RBL-2H3
To further examine the CD8/j-mediated signaling pathway,
we ¢rst transfected a construct of CD8/j chimeric protein in a
rat basophilic leukemia cell line, RBL-2H3, and obtained a
stable transformant, RBL-CD8/j, which showed the constitu-
tive expression of CD8/j on the cell surface (Fig. 4A). RBL-
CD8/j cells were transfected with NF-AT reporter luciferase
construct (NF-AT-LUC) or NF-UB reporter luciferase con-
struct (NF-UB-LUC), treated with OKT8 antibody or iono-
mycin, and LUC activities were determined. As shown in Fig.
4B, OKT8 as well as ionomycin stimulated NF-AT-LUC or
NF-UB-LUC activity, suggesting that CD8/j can transduce
signals in RBL-2H3 cells.
We next examined tyrosine phosphorylation of cellular
PTKs and adapter molecules after stimulation of RNL-2H3
cells by OKT8 (Fig. 4C). Syk, Btk, and Tec PTKs as well as
CD8/j were tyrosine-phosphorylated in RBL-CD8/j cells. Ty-
rosine phosphorylation of downstream adapter molecules,
such as Vav1, SLP-76, Cbl, PLC-Q1 and PLC-Q2, was also
induced by stimulation of OKT8. We could not detect tyro-
sine phosphorylation of LAT in RBL-CD8/j cells, because
LAT co-migrated with highly phosphorylated CD8/j mole-
cules and co-immunoprecipitated with anti-LAT antibody
(data not shown). Another lymphoid-speci¢c adapter protein,
BLNK, was not detected in RBL-CD8/j cells by Western blot
analysis. These results indicate that tyrosine phosphorylation
of CD8/j triggers the activation of PTKs and subsequent
phosphorylation of adapter molecules, leading NF-AT and
NF-UB activation in RBL-2H3 cells.
3.5. Conclusive remarks
The present report describes an involvement of PLC-Q1 in
ITAM- and a hematopoietic cell-speci¢c adapter protein-
mediated NF-AT and NF-UB activation in the non-lymphoid
cells. We demonstrated that a hematopoietic cell-speci¢c
adapter protein, SLP-76 or BLNK, but not LAT, co-operated
with CD8/j, Syk and Tec PTKs in NF-AT and NF-UB acti-
vation in the non-lymphoid cells. In accordance with these
results, tyrosine phosphorylation of endogenous PLC-Q1 by
CD8/j, Syk and Tec PTKs was markedly enhanced by addi-
tional expression of SLP-76 or BLNK but not LAT in the
non-lymphoid cells. Furthermore, a PLC inhibitor suppressed
this NF-AT activation but not NF-UB activation in non-lym-
phoid cells. Regarding LAT, it was shown that LAT is re-
quired for TCR-mediated activation of PLC-Q1 [15]. Our data
imply that LAT requires additional hematopoietic cell-speci¢c
adapter molecules for its link to PLC-Q1 or other negative
regulator molecules may be recruited by the phosphorylation
of LAT by Syk in 293T cells. It has been demonstrated that
overexpression of both Vav1 and SLP-76 synergistically in-
duces TCR-stimulated NF-AT activation [21]. We found
that Vav1 alone activates NF-UB but not NF-AT activation
in 293T cells. However, no functional co-operation between
Vav1 and Syk-Tec-SLP-76 was observed in 293T cells, sug-
gesting that another adapter protein may be required for their
connections on NF-UB or NF-AT activation in 293T cells.
These results indicate that endogenous PLC-Q1 in 293T cells
may play an important role in a hematopoietic cell-speci¢c
adapter protein-mediated NF-AT and NF-UB activation. Fur-
thermore, this novel system in non-lymphoid cells may pro-
vide a useful tool to delineate or identify the regulatory mol-
ecules for TCR-mediated NF-AT and NF-UB activation in the
downstream of CD3j, Syk and Tec family PTKs.
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